Pronova Biopharma Says German Court Rules in Favour on Post-MI

Pronova BioPharma (PRON) ASA said the German Federal Patent Court ruled in Pronova and Pfizer (PFE) Italia’s favor in the patent litigation involving German Patent No. EP 1 152 755 covering Post-MI use in Germany.

To contact the editor responsible for this story: Meera Bhatia at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.